These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 6125883)

  • 41. Evaluation of the mutagenic potential of endosulfan using the Salmonella/mammalian microsome assay.
    Pandey N; Gundevia F; Ray PK
    Mutat Res; 1990 Oct; 242(2):121-5. PubMed ID: 2233828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutagenicity of polycyclic aromatic hydrocarbons and quinones on Salmonella typhimurium TA97.
    Sakai M; Yoshida D; Mizusaki S
    Mutat Res; 1985; 156(1-2):61-7. PubMed ID: 3889628
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolic activation to a mutagen of 3-hydroxy-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene, a secondary metabolite of benzo[a]pyrene.
    Glatt H; Seidel A; Ribeiro O; Kirkby C; Hirom P; Oesch F
    Carcinogenesis; 1987 Nov; 8(11):1621-7. PubMed ID: 3311446
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutagenic activity of phosmet, the active component of the organophosphorus insecticide Decemtione EK 20 in Salmonella and Saccharomyces assays.
    Vlcková V; Miadoková E; Podstavková S; Vlcek D
    Mutat Res; 1993 Jul; 302(3):153-6. PubMed ID: 7686624
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemicals mutagenic in Salmonella typhimurium strain TA1535 but not in TA100.
    Prival MJ; Zeiger E
    Mutat Res; 1998 Feb; 412(3):251-60. PubMed ID: 9600693
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salmonella typhimurium strain TA100 differentiates several classes of carcinogens and mutagens by base substitution specificity.
    Koch WH; Henrikson EN; Kupchella E; Cebula TA
    Carcinogenesis; 1994 Jan; 15(1):79-88. PubMed ID: 8293552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mutation spectra of Glu-P-1 in Salmonella: induction of hotspot frameshifts and site-specific base substitutions.
    Levine JG; Knasmüller S; Shelton ML; DeMarini DM
    Environ Mol Mutagen; 1994; 24(1):11-22. PubMed ID: 8050413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dependence of the mutagenic power of heteroatomic dyes on their DNA-base-pair specificity.
    Mennigmann HD; Müller W
    Mutat Res; 1981 May; 91(3):183-91. PubMed ID: 7017396
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of glutathione and uridine 5'-diphosphoglucuronic acid on benzo(a)pyrene mutagenesis in the Salmonella/microsome assay.
    Malaveille C; Brun G; Hautefeuille A; Bartsch H
    Dev Toxicol Environ Sci; 1980; 8():175-80. PubMed ID: 6273102
    [No Abstract]   [Full Text] [Related]  

  • 50. Mutagenicity of phenanthrene and phenanthrene K-region derivatives.
    Bücker M; Glatt HR; Platt KL; Avnir D; Ittah Y; Blum J; Oesch F
    Mutat Res; 1979 Apr; 66(4):337-48. PubMed ID: 379629
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 4-Chloromethylbiphenyl (4CMB), benzyl chloride (BC) and 4-hydroxymethylbiphenyl (4HMB): reverse mutation tests with Salmonella typhimurium.
    Ladner A
    Mutat Res; 1982; 100(1-4):27-31. PubMed ID: 7035893
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mutation spectrum of cigarette smoke condensate in Salmonella: comparison to mutations in smoking-associated tumors.
    DeMarini DM; Shelton ML; Levine JG
    Carcinogenesis; 1995 Oct; 16(10):2535-42. PubMed ID: 7586163
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Induced mutagenesis in Salmonella typhimurium AG262 strain constructed for screening the mutagens].
    Liamkina II; Andreeva IV; Stepanova NF; Rusina OIu; Skavronskaia AG
    Genetika; 1987 May; 23(5):802-8. PubMed ID: 3305161
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aryl-monoalkyl and cyclic triazenes: direct-acting mutagens.
    Thomas HF; Brown DL; Hartman PE; White EH; Hartman Z
    Mutat Res; 1979 Mar; 60(1):25-32. PubMed ID: 372794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Proflavin: an unusual mutagen.
    Speck WT; Rosenkranz HS
    Mutat Res; 1980 Jan; 77(1):37-43. PubMed ID: 6987510
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heterocyclic amine mutagenicity/carcinogenicity: influence of repair, metabolism, and structure.
    Felton JS; Wu R; Knize MG; Thompson LH; Hatch FT
    Princess Takamatsu Symp; 1995; 23():50-8. PubMed ID: 8844795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence for hormesis in mutagenicity dose-response relationships.
    Calabrese EJ; Stanek EJ; Nascarella MA
    Mutat Res; 2011 Dec; 726(2):91-7. PubMed ID: 21540124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The mutagenicity of nitrite in the Salmonella/microsome test system.
    Balimandawa M; de Meester C; Léonard A
    Mutat Res; 1994 Apr; 321(1-2):7-11. PubMed ID: 7510847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Rat hepatocyte-mediated bacterial mutagenicity in relation to the carcinogenic potency of benz(a)anthracene, benzo(a)pyrene, and twenty-five methylated derivatives.
    Utesch D; Glatt H; Oesch F
    Cancer Res; 1987 Mar; 47(6):1509-15. PubMed ID: 3545447
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The relationship between frameshift mutagenicity and DNA-binding affinity in a series of acridine-substituted derivatives of the experimental antitumour drug 4'-(9-acridinylamino)methanesulphonanilide (AMSA).
    Ferguson LR; Baguley BC
    Mutat Res; 1981 Jun; 82(1):31-9. PubMed ID: 7022171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.